Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$29.28 -0.57 (-1.91%)
At close: Sep 29, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Restructuring Costs (2024)

Updated

Amylyx Pharmaceuticals' Restructuring Costs came in at $22.85 million for FY2024.

Analysis

Amylyx Pharmaceuticals (AMLX) Restructuring Costs (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Amylyx Pharmaceuticals 3.32 Bn 3.32 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 22.85 Mn
API Access

Amylyx Pharmaceuticals Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=AMLX&period=max&api_key=YOUR_API_KEY